Standard FDG PET/CT misses active multiple myeloma in 30% to 50% of patients with biopsy-proven disease.

The wide variation in performance, both across and within facilities, indicates substantial opportunities for improvement.

CEM did not meet the primary trial end point of a 10% treatment change, though CEM findings helped optimize treatment decisions...

The AI pipelines within the platform focused on measuring bone length and fetal MRI.

Researchers created digital twins from patients' knees, and women had greater ACL force than men.